These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34630635)

  • 1. The quest for a better fight: How can nanomaterials address the current therapeutic and diagnostic obstacles in the fight against COVID-19?
    Ranjbar S; Fatahi Y; Atyabi F
    J Drug Deliv Sci Technol; 2022 Jan; 67():102899. PubMed ID: 34630635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancements in protein nanoparticle vaccine platforms to combat infectious disease.
    Butkovich N; Li E; Ramirez A; Burkhardt AM; Wang SW
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 May; 13(3):e1681. PubMed ID: 33164326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced Plasmonic Nanoparticle-Based Techniques for the Prevention, Detection, and Treatment of Current COVID-19.
    Yakoubi A; Dhafer CEB
    Plasmonics; 2023; 18(1):311-347. PubMed ID: 36588744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology-based promising strategies for the management of COVID-19: current development and constraints.
    Rai M; Bonde S; Yadav A; Plekhanova Y; Reshetilov A; Gupta I; Golińska P; Pandit R; Ingle AP
    Expert Rev Anti Infect Ther; 2022 Oct; 20(10):1299-1308. PubMed ID: 33164589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unveiling the Potential Role of Nanozymes in Combating the COVID-19 Outbreak.
    Ali J; Elahi SN; Ali A; Waseem H; Abid R; Mohamed MM
    Nanomaterials (Basel); 2021 May; 11(5):. PubMed ID: 34069866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines.
    Shih HI; Wu CJ; Tu YF; Chi CY
    Biomed J; 2020 Aug; 43(4):341-354. PubMed ID: 32532623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic.
    Weiss C; Carriere M; Fusco L; Capua I; Regla-Nava JA; Pasquali M; Scott JA; Vitale F; Unal MA; Mattevi C; Bedognetti D; Merkoçi A; Tasciotti E; Yilmazer A; Gogotsi Y; Stellacci F; Delogu LG
    ACS Nano; 2020 Jun; 14(6):6383-6406. PubMed ID: 32519842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral Potential of Nanoparticles-Can Nanoparticles Fight Against Coronaviruses?
    Gurunathan S; Qasim M; Choi Y; Do JT; Park C; Hong K; Kim JH; Song H
    Nanomaterials (Basel); 2020 Aug; 10(9):. PubMed ID: 32825737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract.
    Zhang Y; Almazi JG; Ong HX; Johansen MD; Ledger S; Traini D; Hansbro PM; Kelleher AD; Ahlenstiel CL
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies.
    Kumari M; Lu RM; Li MC; Huang JL; Hsu FF; Ko SH; Ke FY; Su SC; Liang KH; Yuan JP; Chiang HL; Sun CP; Lee IJ; Li WS; Hsieh HP; Tao MH; Wu HC
    J Biomed Sci; 2022 Sep; 29(1):68. PubMed ID: 36096815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances of nanomaterials-based strategies for fighting against COVID-19.
    Zeng C; Hou X; Bohmer M; Dong Y
    View (Beijing); 2021 Aug; 2(4):20200180. PubMed ID: 34766161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A proposed insight into the anti-viral potential of metallic nanoparticles against novel coronavirus disease-19 (COVID-19).
    Ibrahim Fouad G
    Bull Natl Res Cent; 2021; 45(1):36. PubMed ID: 33564223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions.
    Khan WH; Hashmi Z; Goel A; Ahmad R; Gupta K; Khan N; Alam I; Ahmed F; Ansari MA
    Front Cell Infect Microbiol; 2021; 11():690621. PubMed ID: 34568087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles in clinical trials of COVID-19: An update.
    Rauf A; Abu-Izneid T; Khalil AA; Hafeez N; Olatunde A; Rahman M; Semwal P; Al-Awthan YS; Bahattab OS; Khan IN; Khan MA; Sharma R
    Int J Surg; 2022 Aug; 104():106818. PubMed ID: 35953020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synopsis of Pharmotechnological Approaches in Diagnostic and Management Strategies for Fighting Against COVID-19.
    Azhar A; Hassan N; Singh M; Al-Hosaini K; Kamal MA
    Curr Pharm Des; 2021; 27(39):4086-4099. PubMed ID: 34269664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnology: A Potential Weapon to Fight against COVID-19.
    Tiwari AK; Mishra A; Pandey G; Gupta MK; Pandey PC
    Part Part Syst Charact; 2022 Jan; 39(1):2100159. PubMed ID: 35440846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.
    Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM
    Elife; 2022 Aug; 11():. PubMed ID: 36004719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotechnology Responses to COVID-19.
    Ruiz-Hitzky E; Darder M; Wicklein B; Ruiz-Garcia C; Martín-Sampedro R; Del Real G; Aranda P
    Adv Healthc Mater; 2020 Oct; 9(19):e2000979. PubMed ID: 32885616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of nanomaterials in COVID-19 pandemic.
    Xiao MF; Zeng C; Li SH; Yuan FL
    Rare Metals; 2022; 41(1):1-13. PubMed ID: 34539132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of nanotechnology in current COVID-19 outbreak.
    Tavakol S; Zahmatkeshan M; Mohammadinejad R; Mehrzadi S; Joghataei MT; Alavijeh MS; Seifalian A
    Heliyon; 2021 Apr; 7(4):e06841. PubMed ID: 33880422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.